Introduction {#section1-2374373517750413}
============

Advances in medical care over the past several decades have resulted in significant survival gains and improvement in health outcomes; however, these innovations have been accompanied by fragmentation of the health-care system and subspecialization of health services. This complexity creates barriers for patients seeking care and exacerbates preexisting inequity, disadvantaging historically disenfranchised populations who may not have the opportunity, access, or financial means to navigate the health-care system. One strategy to address this challenge is to utilize specially trained community health workers, called patient navigators, to identify patient-reported barriers to care and to address larger disparities in health-care access and quality ([@bibr1-2374373517750413]).

Patient navigation (PN) programs were initially developed to address disparities in cancer screening and treatment outcomes among vulnerable populations ([@bibr1-2374373517750413] [@bibr2-2374373517750413] [@bibr3-2374373517750413]--[@bibr4-2374373517750413]). PN programs promote increased participation in cancer screening and adherence to diagnostic follow-up after detection of an abnormality ([@bibr5-2374373517750413]). Similarly, PN programs for cancer screening have been shown to be effective when targeting disenfranchised populations ([@bibr6-2374373517750413] [@bibr7-2374373517750413]--[@bibr8-2374373517750413]). The most successful patient outcomes have been seen in PN programs that focus on cancer screening and outreach among patient populations with navigators whose race and language reflect that of the patient community ([@bibr3-2374373517750413],[@bibr5-2374373517750413],[@bibr6-2374373517750413],[@bibr9-2374373517750413]).

Although PN programs have been implemented in many patient populations and at different stages of cancer care, the correlation between patient satisfaction with PN programs and overall medical care has not been broadly studied ([@bibr3-2374373517750413],[@bibr10-2374373517750413]). Navigators are viewed as an extension of the health-care system, which underscores the importance of investigating the relationship between PN and satisfaction with overall medical care. Patients' experiences with PN may directly impact their views of the health-care system as a whole, particularly as PN becomes part of routine delivery of care. Understanding the relationship between satisfaction with PN and with the health-care system, in general, is important because a positive interaction with a navigator may encourage increased engagement with other dimensions of health care.

Studies utilizing validated surveys to examine satisfaction with cancer care between navigated and non-navigated patients have shown mixed results. Two studies evaluating large, multicenter PN programs found no difference in satisfaction with care between patients randomized to navigation and to usual care following an abnormal cancer screening result ([@bibr10-2374373517750413]--[@bibr11-2374373517750413]). Similarly, a study evaluating PN for women requiring core biopsy after an abnormal breast finding showed no difference in satisfaction between navigated and non-navigated patients ([@bibr12-2374373517750413]). In contrast, an evaluation of a PN program focused on care of minority and low-income women with abnormal mammogram findings found that PN was associated with significantly higher satisfaction with overall medical care and a reduction in patient-reported anxiety ([@bibr3-2374373517750413]). Another recent study among medically underserved patients with a definitive cancer diagnosis has found a significant, positive relationship between PN and satisfaction with overall cancer care ([@bibr13-2374373517750413]). Two additional studies and a systemic review of PN during cancer treatment showed higher satisfaction with care in patients who were navigated ([@bibr14-2374373517750413] [@bibr15-2374373517750413]--[@bibr16-2374373517750413]). In all, although data are mixed, the current literature supports a trend toward improvement in patient satisfaction among patients who have PN for cancer treatment or confirmatory testing.

Differences in the impact of PN on satisfaction with care may be due to variation between programs or to characteristics of the patients targeted by PN. However, to our knowledge, no study to date has employed validated survey instruments to evaluate patient satisfaction with overall medical care---including noncancer care---among patients receiving PN for cancer screening.

The objective of this study was to evaluate patient satisfaction with a novel patient-centered PN program for comprehensive cancer screening among patients at high risk of nonadherence within a large primary care network and to evaluate the relationship between patient satisfaction with navigation and their satisfaction with overall medical care ([@bibr17-2374373517750413]).

Methods {#section2-2374373517750413}
=======

Study Site {#section3-2374373517750413}
----------

The Massachusetts General Primary Care Practice-Based Research Network consists of 18 primary care practices, including 6 community health centers, affiliated with Massachusetts General Hospital. The network has used a population health IT management system in all primary care practices since 2011 to identify patients with an established primary care physician (PCP) who are overdue for breast, cervical, and colorectal cancer screening and automatically sends reminder letters to encourage patients to schedule overdue screening tests. Additionally, the automated system utilizes an algorithm that incorporates patient information including number of overdue tests, primary language spoken, and no-show visit history to identify patients at high risk of nonadherence with cancer screening and refers them to the PN program ([@bibr17-2374373517750413]).

Patient Navigators {#section4-2374373517750413}
------------------

Navigators in the PN program are community health workers experienced in cancer care navigation. Navigators are trained in motivational interviewing, problem-solving, goal setting, and use of the electronic health record system. Each navigator is assigned a panel of high-risk patients to guide in obtaining age-appropriate screening. They contact these high-risk patients via telephone and address overdue cancer screening (colorectal, breast, cervical), focusing on assisting patients with individual barriers to screening. Interaction with a navigator may range from an initial phone call to several discussions, depending on patient need. In addition, navigators take detailed notes about their conversations with patients and communicate with the patients' PCP through the electronic health record. Patient navigation is provided in 5 languages and can offer services using an interpreter for patients who speak other languages.

Participants {#section5-2374373517750413}
------------

Eligible patients from 18 Massachusetts General Hospital primary care practices were part of a randomized control trial designed to evaluate the effectiveness of a PN program for cancer screening. As a part of this larger study conducted between April and December 2014, patients overdue for breast, cervical, and/or colorectal screening and who were identified as being at high risk of nonadherence with screening were randomized to either PN (n = 792) or usual care (n = 820). All patients benefited from the standard of care, such as automated reminder letters, but only those randomized to PN received individualized navigation to help schedule and complete screening during the trial period ([@bibr17-2374373517750413]). Patients were only asked to participate in our satisfaction study if they had the first contact with a navigator after July 2014. Because our study was nested within a larger, ongoing randomized control trial, only 340 PN patients met this inclusion criterion. For comparison, we randomly selected 340 patients in the usual care group for the satisfaction survey.

Study Design and Data Collection {#section6-2374373517750413}
--------------------------------

Telephone surveys were conducted from September 2014 through January 2015. We sent introductory letters about the survey in batches of 80 per week to equal numbers of randomly selected patients in the PN and control arms. No remuneration was offered for participation. Patients were contacted by phone 1 week after the introductory letter was mailed and asked to complete the Patient Satisfaction Questionnaire-18 (PSQ-18). Patients in the PN group were then asked to complete the Patient Satisfaction with Navigation-Interpersonal (PSN-I) questionnaire, in that order. Our research team attempted to contact patients on a minimum of 3 separate occasions at both personal and work telephone numbers. Surveys were administered 1 to 5 months after contact with PN in the patient's preferred language where possible.

Instruments and Measures {#section7-2374373517750413}
------------------------

Several tools have been developed to evaluate patient satisfaction with PN ([@bibr9-2374373517750413],[@bibr18-2374373517750413]). One of the most pertinent tools for evaluating a patient's experience with PN is the PSN-I scale ([@bibr19-2374373517750413]). The PSN-I employs a Likert scale to evaluate patient perception of their interaction with PN, including communication, empathy, and reliability. Patient Satisfaction with Navigation-Interpersonal scores range from 9 to 45, with higher scores indicating better satisfaction. The tool has been validated in both English and Spanish ([@bibr20-2374373517750413]).

For this study, we utilized the PSQ-18 survey to evaluate patient satisfaction with general medical care. Published by the RAND Corporation in 1994, the PSQ-18 "Short-form Patient Satisfaction Questionnaire" is an 18-question survey that employs a 1 to 5 Likert scale to evaluate satisfaction with 7 dimensions of patient care: general satisfaction, technical quality, interpersonal manner, communication, financial aspects, time spent with doctor, and accessibility and convenience. Patient Satisfaction Questionnaire-18 scores range from 18 to 90 with higher scores indicating better satisfaction. The PSQ-18 is publicly available, has been translated into multiple languages, and is validated for the assessment of primary care services ([@bibr21-2374373517750413]).

The institutional review board approved all study activities.

Statistical Analysis {#section8-2374373517750413}
--------------------

We summarized continuous variables using mean (standard deviation) and categorical variables using frequency with percentage. We compared characteristics of respondents in the intervention and control arm using 2-sample *t* tests or χ^2^ tests, as appropriate. We employed 2-sample *t* tests to compare patient satisfaction with overall medical care, as measured by the PSQ-18, between the 2 study arms for all patients and relevant subgroups. In the navigated patients, we also summarized the relationship between patient satisfaction with PN (as measured by PSN-I) and their satisfaction with overall medical care (as measured by PSQ-18) using a Pearson correlation coefficient. We used a 2-way analysis of variance adjustment to address the racial differences between the 2 groups.

Results {#section9-2374373517750413}
=======

Of the 680 patients contacted, 221 (32.5%) agreed to participate and completed the survey (114 \[33.5%\] intervention and 108 \[31.8%\] control). Among patients not agreeing to participate, 104 (15.3%) could not be contacted due to outdated or inaccurate contact information (41 intervention and 63 control), and 81 (11.9%) were reached but declined to participate (31 control, 50 intervention). Two patients selected for navigation by the algorithm died. The remaining patients did not respond to a standard voicemail explaining the project.

Respondents had a mean age of 59.4 years, most were female (57.5%), spoke English (90.0%), and 48.0% had commercial health insurance. Although there were significantly more non--white-navigated respondents, there was no difference in age, gender, primary language, type of insurance, patient--physician connectedness status, or number of clinic visits over the prior 3 years among intervention and control group respondents ([Table 1](#table1-2374373517750413){ref-type="table"}).

###### 

Demographic Characteristics of Navigated And Non-Navigated Patients.

![](10.1177_2374373517750413-table1)

  Characteristics                           Navigated (n = 114)   Non-Navigated (n = 107)   *P* Value
  ----------------------------------------- --------------------- ------------------------- -----------
  Age, mean (SD)                            59.5 (7.9)            59.3 (8.0)                .86
  Gender, female                            66 (57.9%)            61 (57.0%)                .89
  Race, white                               76 (66.7%)            88 (82.2%)                .01
  Primary language, English                 99 (86.8%)            100 (93.5%)               .10
  Insurance                                                                                 .74
   Commercial                               58 (50.9%)            48 (44.9%)                
   Medicaid                                 29 (25.4%)            28 (26.2%)                
   Medicare                                 23 (20.2%)            28 (26.2%)                
   Self-pay                                 4 (3.5%)              3 (2.8%)                  
  Patient--physician connectedness status                                                   .51
   PCP connected                            99 (86.8%)            96 (89.7%)                
   Practice connected                       15 (13.2%)            11 (10.3%)                
  Clinic visits over 3 years, mean (SD)     8.2 (7.1)             9.7 (8.9)                 .19

Abbreviations: PCP, primary care physician; SD, standard deviation.

Patients in the PN (intervention) group had higher satisfaction with their overall medical care compared to control patients (mean PSQ-18: 71.0, standard deviation \[SD\]: 6.33 vs 66.8, SD: 8.39; *P* \< .001). This difference persisted after adjusting for the racial differences between intervention and control groups (adjusted mean PSQ-18: 71.0 vs 66.7; *P* \< .001). Patient satisfaction was also higher among intervention patients in relevant subgroups of age (\<60 and ≥60 years), gender, race (white and non-white), insurance (commercial/Medicare and Medicaid/no insurance), and among English speakers, but not among a very small sample of non--English-speaking patients ([Table 2](#table2-2374373517750413){ref-type="table"}).

###### 

Mean PSQ-18 Scores Among Navigated And Non-Navigated Patients.

![](10.1177_2374373517750413-table2)

                            Navigated   Non-Navigated                      
  ------------------------- ----------- --------------- ----- ------------ --------
  Overall                   114         71.0 (6.3)      107   66.8 (8.4)   \<.001
  Age                                                                      
   \<60 years               62          70.7 (7.1)      52    67.0 (6.8)   .01
   ≥60 years                52          71.4 (5.3)      55    66.5 (9.7)   .002
  Gender                                                                   
   Female                   66          71.5 (5.8)      61    68.7 (7.0)   .02
   Male                     48          70.4 (7.0)      46    64.2 (9.4)   \<.001
  Race                                                                     
   White                    76          71.4 (6.7)      88    66.5 (8.7)   \<.001
   Non-white                38          70.2 (5.6)      19    68.1 (6.7)   .24
  Language                                                                 
   English                  99          71.2 (6.1)      100   66.4 (8.3)   \<.001
   Non-English              15          69.7 (7.6)      7     72.7 (7.4)   .40
  Insurance                                                                
   Commercial or Medicare   23          71.7 (5.9)      28    69.9 (6.6)   .31
   Medicaid or none         91          70.8 (6.4)      79    65.7 (8.7)   \<.001

Abbreviations: PSQ, Patient Satisfaction Questionnaire; SD, standard deviation.

The average PSN-I score among the 114 intervention respondents was 36.7 (SD: 7.6), which is equivalent to 78.6 on a 0 to 100 scale ([@bibr4-2374373517750413]). Among intervention patients, the Pearson correlation coefficient between PSN-I score and PSQ-18 score was 0.5 ([Figure 1](#fig1-2374373517750413){ref-type="fig"}).

![Patient Satisfaction with Interpersonal Relationships with Navigator versus PSQ-18 (navigated patients). PSQ-18 indicates Patient Satisfaction Questionnaire-18.](10.1177_2374373517750413-fig1){#fig1-2374373517750413}

Discussion {#section10-2374373517750413}
==========

Our study examined patient satisfaction with general medical care among individuals overdue and at high risk of screening nonadherence who were randomly assigned to PN or usual care. We found that patients who were randomized to PN had significantly higher overall satisfaction with medical care. In addition, we found a positive relationship between satisfaction with PN and satisfaction with general medical care. These findings have several implications as patient navigators become part of the care team responsible for engaging patients in their health.

First, this study indicates that PN can positively impact a patient's overall satisfaction with medical care, especially the positive interpersonal experience with navigators. This finding suggests that personalized attention via PN may improve satisfaction with overall health care as well as lead to potential improvement of targeted outcomes. Although this study did not evaluate subsequent engagement in general medical care, a likely positive effect of satisfaction with medical care is participation in said care. This is a particular area of interest for future research.

Second, our findings suggest that a PN program guided by an automated algorithm that bypasses PCP referral is generally well received by patients. This has implications for further development of PN as part of population health management because it suggests that PN programs do not necessarily have to rely on PCPs to identify patients who might benefit from navigation ([@bibr22-2374373517750413]).

Although there is mixed published data on the impact of PN on patient satisfaction, recent studies have demonstrated increased satisfaction with medical care among patients receiving PN support for cancer treatment and/or follow-up of an abnormal test result ([@bibr3-2374373517750413], [@bibr13-2374373517750413]). Other studies that do not demonstrate a significant difference in satisfaction with care between navigated and non-navigated patients nevertheless demonstrate that navigated patients are more likely than non-navigated patients to understand what to expect at visits following up abnormal cancer screenings ([@bibr10-2374373517750413],[@bibr23-2374373517750413],[@bibr24-2374373517750413]). Our findings contribute to a growing literature showing a positive relationship between PN and patient satisfaction and mirror the findings of a recent study that demonstrated increased satisfaction with cancer-related care among patients who ranked the interpersonal relationship with their navigators highly ([@bibr25-2374373517750413]).

Our study has few limitations. First, our program took place in a single academic primary care network with a sophisticated, centralized IT system, and established PN program, which may not be generalizable to other primary care networks. In addition, our data are entirely patient-reported and therefore subject to recall bias. We have endeavored to mitigate this bias by only surveying patients with recent PN experience; however, recall bias is an inherent methodological weakness in all survey-based research ([@bibr9-2374373517750413]). To reduce response fatigue, we employed shorter surveys; however, the respondents were asked up to 27 questions and conversations lasted up to 20 minutes, which may have limited willingness to participate. Further, our low-response rate may mean that the results presented here do not reflect the broader population. In addition, because our study design asked patients to opt-in to participate in the satisfaction surveys, our data may be subject to response bias, where patients may have elected to respond only if they had strong positive or negative feelings about PN or health care. Due to the inherent design of this study, the interviewer administering the survey was not blinded to the patient's PN status. Finally, although our study demonstrates significantly higher satisfaction scores among the navigated group, it is unclear whether a difference of 4.3 points on the PSQ-18 is a clinically meaningful difference because, although the questionnaire has been shown to have internal validity, it has not been validated across institutions ([@bibr21-2374373517750413]).

Conclusion {#section11-2374373517750413}
==========

Our data suggest that systematically addressing patient-identified barriers to care using targeted PN for cancer screening may improve patient satisfaction with health-care overall. Specifically, we show that patients at high risk of nonadherence with cancer screening who were automatically referred to a PN program reported a more positive overall experience with medical care than patients not referred to the program within a multisite, academic primary care network.

PN is an important tool that may improve care delivery, equity, and quality of care in large, complex, health-care networks. The goals of PN are aligned with the overarching goals of patient-centered medical home efforts that seek to improve quality of care by promoting health-care coordination and patient satisfaction through patient-centered care. Although this study does not evaluate outcomes or cost effectiveness, it has implications for development of PN programs in that it highlights the positive effects that PN can have on satisfaction with general medical care. As PN programs are established in multiple care delivery environments and become standard of care, common expectations and training for patient navigators as well as standardized metrics for evaluation will be necessary for further evaluations of PN effectiveness and the impact of PN on patient satisfaction ([@bibr26-2374373517750413]).
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